GRAIL’s Stock Slips Below 52‑Week High as Biotech Volatility Continues
GRAIL’s stock hits $124.67 amid volatility—see how its 52‑week highs/lows, $5.47B market cap and early cancer‑detection tech shape investor prospects.
2 minutes to read
GRAIL INC